{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:03:40Z","timestamp":1789405420596,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T00:00:00Z","timestamp":1664064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.canlet.2022.215916","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T18:44:53Z","timestamp":1663440293000},"page":"215916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Delivery of LINC00589 via mesoporous silica nanoparticles inhibits peritoneal metastasis in gastric cancer"],"prefix":"10.1016","volume":"549","author":[{"given":"Shuchang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Wo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunchao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lechun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enhao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2022.215916_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2022.215916_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1245\/s10434-019-07624-0","article-title":"Gastric cancer peritoneal carcinomatosis risk score","volume":"27","author":"Ji","year":"2020","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2022.215916_bib3","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.3748\/wjg.v22.i30.6829","article-title":"Molecular mechanisms of peritoneal dissemination in gastric cancer","volume":"22","author":"Kanda","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2022.215916_bib4","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ijc.28373","article-title":"Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors","volume":"134","author":"Thomassen","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2022.215916_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1039\/C6BM00872K","article-title":"Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors","volume":"5","author":"Castillo","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.canlet.2022.215916_bib6","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/acschembio.5b01053","article-title":"Vectorization of nucleic acids for therapeutic approach: tutorial review","volume":"11","author":"Geinguenaud","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.canlet.2022.215916_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.apsb.2018.01.007","article-title":"Mesoporous silica nanoparticles for drug and gene delivery","volume":"8","author":"Zhou","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.canlet.2022.215916_bib8","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/smll.200900005","article-title":"Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles","volume":"5","author":"Lu","year":"2009","journal-title":"Small"},{"key":"10.1016\/j.canlet.2022.215916_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijpharm.2008.04.010","article-title":"Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery","volume":"359","author":"Park","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.canlet.2022.215916_bib10","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1021\/nn900918w","article-title":"Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs","volume":"3","author":"Xia","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2022.215916_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","article-title":"Functional classification and experimental dissection of long noncoding RNAs","volume":"172","author":"Kopp","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2022.215916_bib12","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.bbagrm.2014.08.012","article-title":"LncRNA: a link between RNA and cancer","volume":"1839","author":"Yang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2022.215916_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12943-015-0355-8","article-title":"Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16","volume":"14","author":"Kong","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215916_bib14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1158\/2159-8290.CD-15-0921","article-title":"LncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern","volume":"6","author":"Sun","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2022.215916_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12943-019-1032-0","article-title":"The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs","volume":"18","author":"Wang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215916_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/hep.29405","article-title":"Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6\/STAT3 signaling pathway","volume":"67","author":"Zhang","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2022.215916_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13577-020-00429-4","article-title":"Long noncoding RNA TSLNC8 enhances pancreatic cancer aggressiveness by regulating CTNNB1 expression via association with HuR","volume":"34","author":"Chai","year":"2021","journal-title":"Hum. Cell"},{"key":"10.1016\/j.canlet.2022.215916_bib18","first-page":"7624","volume":"25","author":"Fan","year":"2019","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.canlet.2022.215916_bib19","first-page":"8440","article-title":"LncRNA TSLNC8 inhibits proliferation of breast cancer cell through the miR-214-3p\/FOXP2 axis","volume":"23","author":"Qin","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2022.215916_bib20","first-page":"5536","article-title":"Long noncoding RNA TSLNC8 suppresses cell proliferation and metastasis and promotes cell apoptosis in human glioma","volume":"18","author":"Chen","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2022.215916_bib21","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1021\/acs.nanolett.8b04236","article-title":"Enhanced drug delivery by nanoscale integration of a nitric oxide donor to induce tumor collagen depletion","volume":"19","author":"Dong","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.canlet.2022.215916_bib22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","article-title":"Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215916_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-019-1122-z","article-title":"Hypoxia induced LUCAT1\/PTBP1 axis modulates cancer cell viability and chemotherapy response","volume":"19","author":"Huan","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215916_bib24","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1038\/s41467-019-11447-8","article-title":"LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc","volume":"10","author":"Tang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2022.215916_bib25","volume":"vol. 8","author":"Roy","year":"2017"},{"key":"10.1016\/j.canlet.2022.215916_bib26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature08697","article-title":"HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer","volume":"463","author":"David","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215916_bib27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ni.3654","article-title":"Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia","volume":"18","author":"Fang","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2022.215916_bib28","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.7150\/thno.44873","article-title":"E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2022.215916_bib29","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/cr.2017.7","article-title":"SPSB1-mediated HnRNP A1 ubiquitylation regulates alternative splicing and cell migration in EGF signaling","volume":"27","author":"Wang","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2022.215916_bib30","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1073\/pnas.0914845107","article-title":"The alternative splicing repressors hnRNP A1\/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism","volume":"107","author":"Clower","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2022.215916_bib31","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1158\/0008-5472.CAN-10-2513","article-title":"Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA","volume":"70","author":"Chen","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2022.215916_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13578-019-0317-8","article-title":"PKM2, function and expression and regulation","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"key":"10.1016\/j.canlet.2022.215916_bib33","first-page":"43","article-title":"Pyruvate kinase: function, regulation and role in cancer, Semin","volume":"43","author":"Israelsen","year":"2015","journal-title":"Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2022.215916_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.semcancer.2019.08.022","article-title":"Functionalized mesoporous silica nanoparticles in anticancer therapeutics","volume":"69","author":"Barkat","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2022.215916_bib35","doi-asserted-by":"crossref","first-page":"19808","DOI":"10.1021\/acsami.9b04474","article-title":"Dual delivery of HNF4\u03b1 and cisplatin by mesoporous silica nanoparticles inhibits cancer pluripotency and tumorigenicity in hepatoma-derived CD133-expressing stem cells","volume":"11","author":"Tsai","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522004037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522004037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:06:29Z","timestamp":1759593989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383522004037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":35,"alternative-id":["S0304383522004037"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215916","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivery of LINC00589 via mesoporous silica nanoparticles inhibits peritoneal metastasis in gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"215916"}}